These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 20144629)

  • 1. Homologous posttranscriptional regulation of insulin-like growth factor-I receptor level via glycogen synthase kinase-3beta and mammalian target of rapamycin in adrenal chromaffin cells: effect on tau phosphorylation.
    Nemoto T; Satoh S; Maruta T; Kanai T; Yoshikawa N; Miyazaki S; Yanagita T; Wada A
    Neuropharmacology; 2010 Jun; 58(7):1097-108. PubMed ID: 20144629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional up-regulation of cell surface Na V 1.7 sodium channels by insulin-like growth factor-1 via inhibition of glycogen synthase kinase-3β in adrenal chromaffin cells: enhancement of 22Na+ influx, 45Ca2+ influx and catecholamine secretion.
    Yanagita T; Satoh S; Uezono Y; Matsuo K; Nemoto T; Maruta T; Yoshikawa N; Iwakiri T; Minami K; Murakami M
    Neuropharmacology; 2011 Dec; 61(8):1265-74. PubMed ID: 21816165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasomal degradation of IRS-2, but not IRS-1 by calcineurin inhibition: attenuation of insulin-like growth factor-I-induced GSK-3beta and ERK pathways in adrenal chromaffin cells.
    Satoh S; Yanagita T; Maruta T; Nemoto T; Yoshikawa N; Kobayashi H; Tono T; Wada A
    Neuropharmacology; 2008 Jul; 55(1):71-9. PubMed ID: 18538359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3beta: homologous regulation of cell surface insulin receptor level via controlling insulin receptor mRNA stability in adrenal chromaffin cells.
    Yokoo H; Nemoto T; Yanagita T; Satoh S; Yoshikawa N; Maruta T; Wada A
    J Neurochem; 2007 Dec; 103(5):1883-96. PubMed ID: 17883398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
    Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
    Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activity of glycogen synthase kinase-3beta: positive regulation of steady-state levels of insulin receptor substrates-1 and -2 in adrenal chromaffin cells.
    Nemoto T; Yokoo H; Satoh S; Yanagita T; Sugano T; Yoshikawa N; Maruta T; Kobayashi H; Wada A
    Brain Res; 2006 Sep; 1110(1):1-12. PubMed ID: 16870161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nav1.7 sodium channel-induced Ca2+ influx decreases tau phosphorylation via glycogen synthase kinase-3beta in adrenal chromaffin cells.
    Kanai T; Nemoto T; Yanagita T; Maruta T; Satoh S; Yoshikawa N; Wada A
    Neurochem Int; 2009 Jul; 54(8):497-505. PubMed ID: 19428794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: the role of GSK-3beta in the maintenance of steady-state levels of insulin receptor signaling molecules and Na(v)1.7 sodium channel in adrenal chromaffin cells.
    Nemoto T; Yanagita T; Kanai T; Wada A
    J Pharmacol Sci; 2009 Feb; 109(2):157-61. PubMed ID: 19179806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of insulin-induced PI3K/Akt/GSK-3beta and ERK signaling by neuronal nicotinic receptor/PKC-alpha/ERK pathway: up-regulation of IRS-1/-2 mRNA and protein in adrenal chromaffin cells.
    Sugano T; Yanagita T; Yokoo H; Satoh S; Kobayashi H; Wada A
    J Neurochem; 2006 Jul; 98(1):20-33. PubMed ID: 16805793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
    Li BG; Hasselgren PO; Fang CH
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2207-16. PubMed ID: 15927518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nav1.7-Ca2+ influx-induced increased phosphorylations of extracellular signal-regulated kinase (ERK) and p38 attenuate tau phosphorylation via glycogen synthase kinase-3beta: priming of Nav1.7 gating by ERK and p38.
    Nemoto T; Miyazaki S; Kanai T; Maruta T; Satoh S; Yoshikawa N; Yanagita T; Wada A
    Eur J Pharmacol; 2010 Aug; 640(1-3):20-8. PubMed ID: 20470771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3 -dependent phosphorylation of Tau.
    Meske V; Albert F; Ohm TG
    J Biol Chem; 2008 Jan; 283(1):100-109. PubMed ID: 17971449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.
    Singh LP; Jiang Y; Cheng DW
    Int J Biol Sci; 2006 Oct; 3(1):27-39. PubMed ID: 17200689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function.
    Li SY; Fang CX; Aberle NS; Ren BH; Ceylan-Isik AF; Ren J
    J Endocrinol; 2005 Sep; 186(3):491-503. PubMed ID: 16135669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells.
    Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A
    Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-induced neurite-like process outgrowth: acceleration of tau protein synthesis via a phosphoinositide 3-kinase~mammalian target of rapamycin pathway.
    Nemoto T; Yanagita T; Satoh S; Maruta T; Kanai T; Murakami M; Wada A
    Neurochem Int; 2011 Nov; 59(6):880-8. PubMed ID: 21854819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation by inhibitor of 90-kDa heat-shock protein family: endoplasmic reticulum retention of monomeric insulin receptor precursor with calnexin in adrenal chromaffin cells.
    Saitoh T; Yanagita T; Shiraishi S; Yokoo H; Kobayashi H; Minami S; Onitsuka T; Wada A
    Mol Pharmacol; 2002 Oct; 62(4):847-55. PubMed ID: 12237331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine-rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase-3β.
    Kawakami F; Shimada N; Ohta E; Kagiya G; Kawashima R; Maekawa T; Maruyama H; Ichikawa T
    FEBS J; 2014 Jan; 281(1):3-13. PubMed ID: 24165324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.